323 related articles for article (PubMed ID: 15768029)
41. Design of functional small interfering RNAs targeting amyotrophic lateral sclerosis-associated mutant alleles.
Geng CM; Ding HL
Chin Med J (Engl); 2011 Jan; 124(1):106-10. PubMed ID: 21362317
[TBL] [Abstract][Full Text] [Related]
42. Gene Therapy for ALS: progress and prospects.
Azzouz M
Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
[TBL] [Abstract][Full Text] [Related]
43. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
[TBL] [Abstract][Full Text] [Related]
44. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.
Wu R; Wang H; Xia X; Zhou H; Liu C; Castro M; Xu Z
Antioxid Redox Signal; 2009 Jul; 11(7):1523-34. PubMed ID: 19344276
[TBL] [Abstract][Full Text] [Related]
45. RNA interference and amyotrophic lateral sclerosis.
Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
[TBL] [Abstract][Full Text] [Related]
46. [Gene therapy of ALS with RNA interference].
Yokota T
Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
[TBL] [Abstract][Full Text] [Related]
47. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.
Biferi MG; Cohen-Tannoudji M; Cappelletto A; Giroux B; Roda M; Astord S; Marais T; Bos C; Voit T; Ferry A; Barkats M
Mol Ther; 2017 Sep; 25(9):2038-2052. PubMed ID: 28663100
[TBL] [Abstract][Full Text] [Related]
48. Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.
Nanou A; Higginbottom A; Valori CF; Wyles M; Ning K; Shaw P; Azzouz M
Mol Ther; 2013 Aug; 21(8):1486-96. PubMed ID: 23732987
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
[TBL] [Abstract][Full Text] [Related]
50. [Gene therapy of ALS with short interfering RNA].
Yokota T
Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
[TBL] [Abstract][Full Text] [Related]
51. RNA interference protects against ALS in mouse model.
Burton A
Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
[No Abstract] [Full Text] [Related]
52. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
Patel P; Kriz J; Gravel M; Soucy G; Bareil C; Gravel C; Julien JP
Mol Ther; 2014 Mar; 22(3):498-510. PubMed ID: 24394188
[TBL] [Abstract][Full Text] [Related]
53. Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice.
Towne C; Setola V; Schneider BL; Aebischer P
Mol Ther; 2011 Feb; 19(2):274-83. PubMed ID: 21102563
[TBL] [Abstract][Full Text] [Related]
54. Vascular physiology and protein disposition in a preclinical model of neurodegeneration.
Boswell CA; Mundo EE; Johnstone B; Ulufatu S; Schweiger MG; Bumbaca D; Fielder PJ; Prabhu S; Khawli LA
Mol Pharm; 2013 May; 10(5):1514-21. PubMed ID: 23383983
[TBL] [Abstract][Full Text] [Related]
55. siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme.
Yokota T; Miyagishi M; Hino T; Matsumura R; Tasinato A; Urushitani M; Rao RV; Takahashi R; Bredesen DE; Taira K; Mizusawa H
Biochem Biophys Res Commun; 2004 Jan; 314(1):283-91. PubMed ID: 14715277
[TBL] [Abstract][Full Text] [Related]
56. Retrogradely transported siRNA silences human mutant SOD1 in spinal cord motor neurons.
Rizvanov AA; Mukhamedyarov MA; Palotás A; Islamov RR
Exp Brain Res; 2009 May; 195(1):1-4. PubMed ID: 19259649
[TBL] [Abstract][Full Text] [Related]
57. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.
Kliem MA; Heeke BL; Franz CK; Radovitskiy I; Raore B; Barrow E; Snyder BR; Federici T; Kaye Spratt S; Boulis NM
Amyotroph Lateral Scler; 2011 Sep; 12(5):331-9. PubMed ID: 21864053
[TBL] [Abstract][Full Text] [Related]
58. Treatment of a Mouse Model of ALS by In Vivo Base Editing.
Lim CKW; Gapinske M; Brooks AK; Woods WS; Powell JE; Zeballos C MA; Winter J; Perez-Pinera P; Gaj T
Mol Ther; 2020 Apr; 28(4):1177-1189. PubMed ID: 31991108
[TBL] [Abstract][Full Text] [Related]
59. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis).
Ende N; Weinstein F; Chen R; Ende M
Life Sci; 2000 May; 67(1):53-9. PubMed ID: 10896029
[TBL] [Abstract][Full Text] [Related]
60. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice.
Dirren E; Aebischer J; Rochat C; Towne C; Schneider BL; Aebischer P
Ann Clin Transl Neurol; 2015 Feb; 2(2):167-84. PubMed ID: 25750921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
